Croda completes acquisition of Solus Biotech

About this update from Croda International Plc

Regulatory News Release 4 July 2023 Croda successfully completes acquisition of Solus Biotech   Croda International Plc ('Croda') today confirms that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients for beauty care and pharmaceuticals.   This follows the announcement on 6 February 2023 that Croda had reached an agreement to acquire Solus Biotech.   -ENDS-   Further information: Investors: David Bishop, Croda                                              +44 7823 874428 Media: Charlie Armitstead, Teneo                                          +44 7703 330269   About Croda: Croda is the company that uses smart science to create high performance ingredients and technologies that improve lives. For m ore information see: www.croda.com .  

View stock analysis, news, and events for Croda International Plc